MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma.	https://doi.org/10.1074/jbc.M112.396762	2012	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Morphine modulates cell proliferation through mir133b &mir128 in the neuroblastoma SH-SY5Y cell line	https://doi.org/10.1016/j.bbadis.2014.01.003	2014	Cell line 0 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Cisplatin regulates SH-SY5Y cell growth through downregulation of BDNF via miR-16	https://doi.org/10.3892/or.2013.2731	2013	Cell line 1 Master/Detail View	Cell line and drug 1 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-432 contributes to dopamine cocktail and retinoic acid induced differentiation of human neuroblastoma cells by targeting NESTIN and RCOR1 genes	https://doi.org/10.1016/j.febslet.2014.03.015	2014	Cell line 1 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Downregulation of tumor suppressor menin by miR-421 promotes proliferation and migration of neuroblastoma	https://doi.org/10.1007/s13277-014-1921-1	2014	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47.	https://doi.org/10.18632/oncotarget.6227	2015	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p	https://doi.org/10.3892/ijo.2017.4110	2017	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
The lncRNA HOXA11-AS regulates Rab3D expression by sponging miR-125a-5p promoting metastasis of osteosarcoma	https://doi.org/10.2147/CMAR.S196025	2019	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-326 is a diagnostic biomarker and regulates cell survival and apoptosis by targeting Bcl-2 in osteosarcoma	https://doi.org/10.1016/j.biopha.2016.10.008	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
microRNA-338-3p inhibits proliferation, migration, invasion, and EMT in osteosarcoma cells by targeting activator of 90 kDa heat shock protein ATPase homolog 1	https://doi.org/10.1186/s12935-018-0551-x	2018	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-466 inhibits osteosarcoma cell proliferation and induces apoptosis by targeting CCND1	https://doi.org/10.3892/etm.2018.6888	2918	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-336 directly targets Sox-2 in osteosarcoma to inhibit tumorigenesis	https://doi.org/10.3892/mmr.2017.6493	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A	https://doi.org/10.1016/j.febslet.2013.11.036	2014	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
The evolutionary young miR-1290 favors mitotic exit and differentiation of human neural progenitors through altering the cell cycle proteins	https://doi.org/10.1038/cddis.2013.498	2014	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha	https://doi.org/10.1038/onc.2012.574	2014	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Early targets of miR-34a in neuroblastoma	https://doi.org/10.1074/mcp.M113.035808	2014	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-181c modulates the proliferation, migration, and invasion of neuroblastoma cells by targeting Smad7	https://doi.org/10.1093/abbs/gmt124	2014	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Regulation by miR181 family of the dependence receptor CDON tumor suppressive activity in neuroblastoma	https://doi.org/10.1093/jnci/dju318	2014	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 4 Master/Detail View
MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression	https://doi.org/10.1111/febs.12074	2013	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Transcriptional regulation of gene expression by microRNAs as endogenous decoys of transcription factors	https://doi.org/10.1159/000362952	2014	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View

Publications